體外循環對機體細胞免疫功能的影響
...CD20)陽性細胞百分率。血常規檢測白細胞(WBC)和淋巴細胞(IY)計數。 1.3 統計學處理 RBC-C3b、RBC-IC、CD3、CD4、CD8、CD57、CD20測定值均爲百分數,均經平方根反正弦變換使數據接近正態分佈。觀察指標均取各時點測定值與術前測...
合作平臺;醫學論文;臨牀醫學與專科論文;檢驗醫學電化學療法中陣列電極的結構與場分析
...數表示爲[10,11]:F1(z)=C1In1z-z1+°a$k=1A1k(z-z1)-k,z=x+iy爲xoy平面任意點的複數表示,z1爲從原點到第一根電極中心的距離,A1k爲與(ab)k有關的係數。其它幾根電極在平面的解是類似的。平面任意一點的電位就是6根電極在這...
醫源資料庫;在線期刊;中華實用醫藥雜誌;2005年第5卷第15期股骨偏心距與全髖關節置換術後關節功能的臨牀分析
...ofthelengthoffemoraloffsetcanreinforcethetensionofabductor,enhancethestabiliy,widenthemotorrangeofrosthesis,decreacethewornoutofpolyethyleneandsterilecinchaswellasprolongthelifespanofprosthesis. 【Keywords】totalhipreplacement,offset,softtissuebalancing 隨着全髖關節置換術(to...
醫源資料庫;在線期刊;濱州醫學院學報;2009年第32卷第4期ABCA1-InducedCellSurfaceBindingSitesforApoA-I
...disruptionoftheN-terminaldomainbyinsertingaprolineresidueinthatregion(apoA-IY18P)hadnoeffectontotalcellbinding(Table).Figure5.InfluenceofC-terminaldeletionsinapoA-Ionbindingtocells,ABCA1,andphospholipidSUV:Thebindingandcross-linkingcharacteristicsoftheC-terminalmutants(190to243,223to243)weredetermin...
醫源資料庫;在線期刊;動脈硬化血栓血管生物學雜誌;2007年第27卷第7期AdrenomedullinEnhancesTherapeuticPotencyofMesenchymalStemCellsAfterExperimentalStrokeinRats
...ftheOrganizationforPharmaceuticalSafetyandResearchofJapan.ReferencesChenJ,LiY,WangL,ZhangZ,LuD,LuM,ChoppM.Therapeuticbenefitofintravenousadministrationofbonemarrowstromalcellsaftercerebralischemiainrats.Stroke.2001;32:1005–1011.ChenJ,ZhangZG,LiY,WangL,XuYX,GautamSC,LuM,ZhuZ,ChoppM.Intravenousadmin...
醫源資料庫;在線期刊;中風學雜誌;2005年第36卷第4期Cadherin-11基因與關節形成
...qing400038,China Abstract:Cadherin-11isakindofclassicalcadherinsubfamliy.Thefunctionofcadherin-11involvesembryonicdevelopment,tissuemorphogenesis,tumor’sinvasionandmetastasis,signaltransductionandsoon.Thisreviewsummarizesthefunctionofcadherin-11injointformation,includingtherelationofcadhe...
醫源資料庫;在線期刊;中國矯形外科雜誌;2009年第17卷第15期Nonosmoticreleaseofvasopressinandrenalaquaporinsinimpairedurinarydilutioninhypothyroidism
...ilurerat.JClinInvest99:15001505,1997.YamamuraY,OgawaH,YamashitaH,ChiharaT,MiyamotoH,NakamuraS,OnogawaT,YamashitaT,HosokawaT,MoriT,TominagaM,andYabuuchiY.Characterizationofanovelaquareticagent,Opc-31260,asanorallyeffective,nonpeptidevasopressinV2-receptorantagonist.BrJPharmacol105:787791,1992.作者...
醫源資料庫;在線期刊;美國生理學雜誌;2005年第288卷第8期Toll-LikeReceptors2-DeficientMiceAreProtectedAgainstPostischemicCoronaryEndothelialDysfunction
...cPhysiol.2007;292:H503-H509.ShishidoT,NozakiN,YamaguchiS,ShibataY,NitobeJ,MiyamotoT,TakahashiH,ArimotoT,MaedaK,YamakawaM,TakeuchiO,AkiraS,TakeishiY,KubotaI.Toll-likereceptor-2modulatesventricularremodelingaftermyocardialinfarction.Circulation.2003;108:2905-2910.NozakiN,ShishidoT,TakeishiY,KubotaI.Mo...
醫源資料庫;在線期刊;動脈硬化血栓血管生物學雜誌;2007年第27卷第5期FunctionalrescueofvasopressinV2receptormutantsinMDCKcellsbypharmacochaperones:relevancetotherapyofnephrogenicdiabetesinsipidus
...iabetesinsipidus.PediatrNephrol16:1146-1152,2001.KondoK,OgawaH,YamashitaH,MiyamotoH,TanakaM,NakayaK,KitanoK,YamamuraY,NakamuraS,OnogawaT.7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine(OPC-41061):apotent,orallyactivenonpeptideargininevasopressinV2r...
醫源資料庫;在線期刊;美國生理學雜誌;2007年第290卷第1期生物化學考研習題
...團既可爲H+的受體,也可爲H+的供體A、His—咪唑基B、Iys—ε—氨基C、Arg—胍基D、Cys—巰基91、利用基因工程的手段,包括基因的定點突變等改造蛋白質分子,使之具有更完善,更能符合人類要求的功能,這種...
醫源資料庫;醫源習題集;生物化學